menu
    • menu

    Company profile for VYNE Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. We make a habit of asking “Why?” – and “Why not?” Our vision is already taking shape. With our expertise in topical medicine innovation as a springboard, we’re working to develop and commercialize so...
    VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. We make a habit of asking “Why?” – and “Why not?” Our vision is already taking shape. With our expertise in topical medicine innovation as a springboard, we’re working to develop and commercialize solutions that were long thought impossible.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VYNE TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    520 U.S. Highway 22, Suite 204, Bridgewater, NJ, USA
    Telephone
    Telephone
    +1 800 775-7936
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vynetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vynetx
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VYNEtx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VYNE Therapeutics And Yarrow Bioscience Announce Merger Agreement
    VYNE Therapeutics And Yarrow Bioscience Announce Merger Agreement

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206928/0/en/VYNE-Therapeutics-and-Yarrow-Bioscience-Announce-Merger-Agreement.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    VYNE Therapeutics Reveals 2025 Q3 Financials & Business Update
    VYNE Therapeutics Reveals 2025 Q3 Financials & Business Update

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182521/0/en/VYNE-Therapeutics-Reports-2025-Third-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    VYNE Therapeutics reports Q2 2025 financials, updates on business
    VYNE Therapeutics reports Q2 2025 financials, updates on business

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133434/0/en/VYNE-Therapeutics-Reports-2025-Second-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Vyne's BET Inhibitor Fails Phase 2 Vitiligo Trial, Sinking Stock
    Vyne's BET Inhibitor Fails Phase 2 Vitiligo Trial, Sinking Stock

    31 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vynes-lead-bet-inhibitor-fails-phase-2-vitiligo-trial-sinking-stock

    FIERCE BIOTECH
    31 Jul 2025
    Share Share
    VYNE Therapeutics Updates on Oral BET inhibitor VYN202
    VYNE Therapeutics Updates on Oral BET inhibitor VYN202

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109093/0/en/VYNE-Therapeutics-Provides-Program-Update-on-Oral-BET-inhibitor-VYN202.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share
    VYNE Therapeutics Reports 2025 Q1 Financials and Business Update
    VYNE Therapeutics Reports 2025 Q1 Financials and Business Update

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077195/0/en/VYNE-Therapeutics-Reports-2025-First-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search